← Home / Erasca, Inc. (ERAS)
Stock Analysis
Erasca, Inc. (ERAS)
ERAS
ERAS · Market data
18.15 -2.84%
Track ERAS in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when ERAS price is:
52W Range Position
80%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-02 20:29 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 22.47. Holding above 16.80 keeps the current thesis intact.
⚖️
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
16.80
↗
Break Above
Confirmation improves above resistance.
22.47
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 16.80
Recent Company Events
SEC VERIFIED
Latest material filings
MAY
11
●
Financial Results
HIGH
Erasca Reports First Quarter 2026 Business Updates and Financial Results
Robust monotherapy efficacy and generally well-tolerated safety results observed during dose escalation for ERAS-0015 in both KRAS G12X NSCLC and PDAC reinforce best-in-class potential across RAS-targeted agents ERAS-0015 monotherapy expansion and combination dose escalation data expected in H1 2027; ERAS-4001 Phase...
8-K Filing • SEC EDGAR
What's Driving ERAS?
📈 Technical recovery is improving
Momentum is Neutral. Watch 22.47 for confirmation and 16.80 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 16.80
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
21.03
RSI(14)
51.3
◎
How to read this setup
The nearest decision zone is framed by support around 16.80 and resistance near 19.07. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
ERAS — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$5.6B
Company size
EV
$5.6B
Debt-adjusted value
P/E
-45.3
Not meaningful
P/B
14.3
Premium
EV/EBIT
-39.7
Not meaningful
FCF Yield
-1.62%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
📈 Net Income
-183.44M
≈ Insufficient
🧮 EPS (Basic)
-0.60
≈ Insufficient
Erasca, Inc.
Related Opportunities